Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

AYTU BIOPHARMA, INC (AYTU) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 10-K Annual Report for the period ended June 30, 2023
10/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/03/2023 4 PYSZCZYMUKA GREG (Chief Commercial Officer) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Exercised 208 restricted stock units @ $0
09/29/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
09/27/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2023 4 Disbrow Jarrett (Chief Business Officer) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 7,000 options to buy @ $1.73, valued at $12.1k
08/15/2023 4 JAIN ABHINAV (Director) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 1,500 shares @ $0
08/15/2023 4 LIU VIVIAN H (Director) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 1,500 shares @ $0
08/15/2023 4 Donofrio John Jr. (Director) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 1,500 shares @ $0
08/15/2023 4 DOCKERY CARL (Director) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 1,500 shares @ $0
08/15/2023 4 Disbrow Joshua R. (CEO) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 35,000 options to buy @ $1.73, valued at $60.6k
08/15/2023 4 BROOKE CHRISTOPHER (COO) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 7,000 options to buy @ $1.73, valued at $12.1k
08/15/2023 4 Oki Mark K (CFO) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 13,000 options to buy @ $1.73, valued at $22.5k
08/15/2023 4 PYSZCZYMUKA GREG (Chief Commercial Officer) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Granted 7,000 options to buy @ $1.73, valued at $12.1k
08/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/31/2023 8-K Quarterly results
07/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
07/06/2023 4 PYSZCZYMUKA GREG (Chief Commerical Officer) has filed a Form 4 on AYTU BIOPHARMA, INC
Txns: Exercised 208 restricted stock units @ $0
06/16/2023 SC 13D/A Nantahala Capital Management, LLC reports a 19.7% stake in AYTU BIOPHARMA, INC.
06/16/2023 SC 13G Stonepine Capital Management, LLC reports a 10% stake in Aytu BioPharma, Inc.
06/12/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Opinion of Dorsey & Whitney LLP",
"Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director"
06/12/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
06/09/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
06/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/06/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
06/05/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/26/2023 SC 13D Nantahala Capital Management, LLC reports a 7.2% stake in AYTU BIOPHARMA, INC.
05/11/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/01/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
05/01/2023 8-K Quarterly results
04/27/2023 8-K Quarterly results
04/19/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy